Vascular BioSciences Announces New Preclinical Research Results Demonstrating Improved Pulmonary Hypertension and Sepsis Survival with CAR Peptide
CEO of Vascular BioSciences, David Mann, makes connection between current research and COVID-19 applications. - June 05, 2020
FDA Grants Vascular BioSciences Humanitarian Use Device (HUD) Designation to the Endoarterial Biopsy Catheter for Group 1 Pulmonary Arterial Hypertension
Vascular Biosciences (VBS) is pleased to announce the receipt of a Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA) for the Endoarterial Biopsy Catheter (EABC) to take pulmonary artery biopsies in patients who have Group 1 pulmonary arterial hypertension... - September 06, 2019
Vascular BioSciences Awarded $2 Million Phase II STTR Grant From NHLBI to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension
Grant awarded in partnership with Brigham and Women’s Hospital, Harvard Medical School. - October 20, 2018
Vascular BioSciences Awarded Up to $2.3 Million Fast-Track STTR Grant from NHLBI To Develop CAR Peptide for Pulmonary Hypertension
Project to be Conducted in Collaboration with Brigham and Women’s Hospital, Harvard Medical School. Vascular BioSciences announced today it has an award for a Phase I/II Fast-Track STTR grant in collaboration with Brigham and Women’s Hospital, Harvard Medical School. The STTR... - September 08, 2017
Vascular Biosciences Announces Publication of "Assessment of MicroRNA and Gene Dysregulaton in Pulmonary Hypertension by Endoarterial Biopsy"
The article details how an endoarterial biopsy offers potential experimental and clinical diagnostic value by successfully showing that a large number of miRNAs that control PH-associated genes, molecular pathways, and biological processes are dysregulated in a porcine shunt model of PH. - May 28, 2017
Vascular BioSciences Congratulates VP of Communications, Dr Susana Peinado, Ph.D., on Being Awarded Her Doctorate from UCSB School of Communication
Newly awarded PhD, Dr. Susana Peinado, lauded for her achievements. - June 05, 2016
Vascular BioSciences Awarded Phase 1 STTR Grant from the National Heart Lung Blood Institute of the National Institutes of Health for Pulmonary Hypertension Research
Vascular BioSciences announced today it has received a STTR Phase 1 grant from the National Heart Lung Blood Institute of the National Institutes of Health in the amount of $165,745. The STTR award, “Targeting Pulmonary Hypertension with R-Ras,” will be performed in collaboration with... - February 10, 2008